Radiation Oncology Resident

Questions from blue book staging and treatment "handbook of evidence-based radiation oncology" by Hansen and Roach 2007. Skin and CNS.

545 cards   |   Total Attempts: 185
  

Cards In This Set

Front Back
Size criteria for T2 non-melanoma skin cancer
More than 2cm but not more than 5cm
5 year local control for RT for T3 SCC non melanoma skin cancer
50%
Post-op indications for non-melanoma skin cancer
Positive margins, PNI of named nerve, larger than 3cm primary, extensive skeletal muscle, bone, or cartilage invasion, SCC of the parotid
Contraindications for non-melanoma skin cancer XRT
Age
Margins for nonmelanoma skin cancer 2cm sized primaries?
0.5-1.0cm and 1.5 to 2.0cm
Dose for 2cm, and >2cm with cartilage involvement of nonmelanoma skin cancer
45-50gGy, 50-55Gy, 60-66Gy
Distant met % in Merkel Cell Carcinoma
50-60%
Dose for Merkel Cell Carcinoma - N0, microscopic disease, microscopic with +margins, macroscopic
N0 45-50Gy, microscopic 45-50Gy, positive margin microscopic 55-60Gy, macroscopic 55-60Gy
3yr OS for Merkel Cell for stage I, II, III
I - 70-80%, II - 50-60%, III - 30%
Most important prognostic factor for melanoma recurrence and survival
SLN status
What is the stage of a 2.5 mm thick melanoma with ulceration
T3b
What is stage of 1.5mm thick melanoma with ulceration and satellite metastasis without positive node
T2bN2c, stage grouping IIIB
What are indications for adjuvant XRT with melanoma
Multiple LN, matted LN, or ECE
What was the outcome of the melanoma RTOG 8305 trial of 32Gy in 4 fx vs 50Gy in 20 fx.
No difference
What is the melanoma follow up for stage IB-III
Q3-6mo for 3 years, then q4-12 months for 2 years, then annually